JPMorgan Chase & Co’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17K	Buy	+2,780	New	+$17K	﹤0.01%	5352
2025 Q1	–	Sell	-3	Closed	-$24	–	6639
2024 Q4	$24	Buy	+3	New	+$24	﹤0.01%	6193